• SPX
  • 6090.27
  • 0.25 %
  • 15.1602
  • DJI
  • 44642.52
  • -0.28 %
  • -123.1914
  • N225
  • 39091.17
  • -0.77 %
  • -304.4297
  • FTSE
  • 8308.61
  • -0.49 %
  • -40.7695
  • IXIC
  • 19859.773
  • 0.81 %
  • 159.0508
Virax Biolabs Group Limited (VRAX) Financials

Virax Biolabs Group Limited (VRAX) Financials

NASDAQ Currency in USD Disclaimer

Stock Price

$1.76

$0.05

(2.89%)

Day's range
$1.67
Day's range
$1.84
Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.

VRAX Income statement / Annual

Last year (2024), Virax Biolabs Group Limited's total revenue was $156,419.00, an increase of 1,727.11% from the previous year. In 2024, Virax Biolabs Group Limited's net income was -$6.73 M. See Virax Biolabs Group Limited’s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020
Period Ended 03/31/2024 03/31/2023 03/31/2022 03/31/2021 03/31/2020
Operating Revenue $156,419.00 $8,561.00 $0.00 $123,820.00 $99,876.00
Cost of Revenue $105,829.00 $9,926.00 $0.00 $133,254.00 $54,127.00
Gross Profit $50,590.00 -$1,365.00 $0.00 -$9,434.00 $45,749.00
Gross Profit Ratio 0.32 -0.16 0 -0.08 0.46
Research and Development Expenses $1.56 M $397,109.00 $433,743.00 $120,221.00 $87,000.00
General & Administrative Expenses $4.59 M $5.31 M $1.29 M $457,680.00 $602,303.00
Selling & Marketing Expenses $0.00 $26,616.00 $13,818.00 $57,203.00 $7,690.00
Selling, General & Administrative Expenses $4.59 M $5.33 M $1.30 M $514,883.00 $609,993.00
Other Expenses $390,355.00 $290,466.00 $0.00 $266.00 $2,470.00
Operating Expenses $6.55 M $5.73 M $1.73 M $635,104.00 $696,993.00
Cost And Expenses $6.65 M $5.74 M $1.73 M $768,358.00 $751,120.00
Interest Income $0.00 $15,468.00 $15,438.00 $28,643.00 $90,690.00
Interest Expense $26,878.00 $15,468.00 $15,438.00 $28,643.00 $90,690.00
Depreciation & Amortization $103,099.00 $1.00 $1.73 M $644,538.00 $651,244.00
EBITDA -$6.61 M -$5.44 M -$750.00 $0.00 -$648,774.00
EBITDA Ratio -42.25 -669.64 0 -5.21 -6.5
Operating Income Ratio -41.53 -669.64 0 -5.21 -6.52
Total Other Income/Expenses Net -$242,647.00 $274,998.00 -$16,191.00 -$28,377.00 -$88,220.00
Income Before Tax -$6.74 M -$5.46 M -$1.75 M -$672,915.00 -$739,464.00
Income Before Tax Ratio -43.08 -637.51 0 -5.43 -7.4
Income Tax Expense $0.00 -$271.00 -$1.77 M -$666,469.00 $61,667.00
Net Income -$6.73 M -$5.46 M -$1.71 M -$650,984.00 -$801,131.00
Net Income Ratio -43.05 -637.48 0 -5.26 -8.02
EPS -3.36 -5.13 -1.5 -0.57 -0.7
EPS Diluted -3.36 -5.13 -1.5 -0.57 -0.7
Weighted Average Shares Out $2.01 M $1.06 M $1.14 M $1.14 M $1.14 M
Weighted Average Shares Out Diluted $2.01 M $1.06 M $1.14 M $1.14 M $1.14 M
Link
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.